Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-027870

Exec. Director, Finance - PAO sold 445 shares at $10.90 ($4,851)

From the SEC's structured data for this filing

Trades in this filing

Jones Michael L · Exec. Director, Finance - PAO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-15 Sale : show line 1 in the form −445 $10.90 $4,851 10,753 D
Open-market sales · 445 sh · avg $10.90 · $4,851
Loading xslF345X03/form4.xml…